Back to
Capital Fund Management S.A.
VKTX
Showing 5 of 11 quarters
Position history for
Capital Fund Management S.A.'s holdings in Viking Therapeutics, Inc.
Yes. Capital Fund Management holds 75,216 shares of VKTX (Viking Therapeutics), worth $2.9M, as of its Q2 2026 13F filing. It increased the position from 20,824 shares in Q1 2026. Capital Fund Management has held VKTX since Q4 2025, across 3 quarterly 13F filings.
Current Value
$2.9M
Current Shares
75,216
Total Value Change
-$1.9M
Total Shares Change
-551
Quarter-by-Quarter History